As of 2023, the measles-containing-vaccine second-dose (MCV2) immunization coverage in France was 88% of children of the nationally recommended age. The forecasted data indicates a steady increase in coverage from 89% in 2024 to 93% in 2028, with a year-on-year growth of approximately 1% each year. The compound annual growth rate (CAGR) over this five-year period is projected to be about 1.1%.

Future trends to watch for:

Continued governmental efforts to improve immunization rates, targeting hard-to-reach populations and addressing vaccine hesitancy.
Potential policy changes based on epidemiological outcomes and public health needs.
Impact of technological advances in vaccine distribution and monitoring systems.